Maggie is a senior editor for The American Journal of Managed Care® (AJMC®) and produces written, video, and podcast content covering several disease states. She joined AJMC® in 2019, and has been with AJMC®’s parent company, MJH Life Sciences®, since 2014, when she started as a copy editor.
She has a BA in English from Penn State University. You can connect with Maggie on LinkedIn.
Oncology Groups Issue Preliminary COVID-19 Triage Guidelines for Breast Cancer
Several prominent oncology organizations, including the National Comprehensive Cancer Network and the Commission on Cancer, have joined forces to issue preliminary guidelines on how to treat patients with breast cancer during the coronavirus disease 2019 (COVID-19) pandemic.
Are Current Blood Iron Levels Appropriate for Use in Patients With Heart Failure?
The chemical symbol for iron is Fe, which stems from the Latin word for iron, Ferrum. Therefore, it is easy to see the connection on how ferritin is the protein responsible for iron storage and release in the body and transferrin is the protein responsible for transporting that iron.
Regular Exercise Confers a Significant Survival Benefit Among Patients With Breast Cancer
Meeting HHS’ minimum requirements for daily and weekly exercise reduced breast cancer recurrence and mortality among patients with high-risk breast cancer undergoing chemotherapy. This benefit was even seen in patients who had not met these requirements before their diagnosis.
Minority, Female, and Older Patients Remain Underrepresented in ACS Clinical Trials
Does patient representation in trials of acute coronary syndrome (ACS) correlate with epidemiologic studies of patients with the condition? According to recent results published in JAMA Cardiology, older patients, women, and black patients continue to be underrepresented in ACS trials.
Close to 100% of Active Duty Service Members Initiate ART and Achieve Viral Suppression, CDC Reports
Between 2012 and 2018, 93.8% of HIV-positive active military service members were on continuous antiretroviral therapy (ART). Of this group, 99.0% were virally suppressed by the end of their first year on ART.
Study Results Show Pembrolizumab Plus Chemotherapy May Be Effective in Patients With TNBC
The standard therapy for triple-negative breast cancer (TNBC) remains chemotherapy, despite a dismal prognosis due to lack of estrogen and progesterone hormone receptors, as well as HER2 receptors. Targeted therapies for this difficult-to-treat, often aggressive, subtype of breast cancer remain elusive.
Heart Failure Plus Pollution Appears to Increase Dementia Risk, Study Indicates
Almost 70% of the world’s population could be living in urban areas, being continuously exposed to air pollution, by 2050, while cases of dementia are expected to triple. Recent study results highlight the link between cardiovascular disease and dementia, as mediated by long-term exposure to air pollution.
Depression Symptoms Show Improvement Following Innovative Magnetic Brain Stimulation Treatment
Repetitive transcranial magnetic stimulation of the brain has been shown to reduce the effects of treatment-resistant depression, but study results show that intermittent theta-burst stimulation may be more efficient and effective.
FDA's Revised Blood Donation Guidance for Gay Men Still Courts Controversy
The FDA has announced a relaxing of its restrictions on gay men being allowed to donate blood, in light of the coronavirus disease 2019 pandemic. Instead of 1 year, if a male has had sex with another male, he need only wait 3 months to donate blood.
White Blood Cell Profile Linked to Greater Breast Cancer Risk
What can be done to further delineate the risk factors associated with breast cancer to increase prevention efforts across the board? The key may lie in the white blood cells that circulate in the blood, particularly leukocytes and monocytes.
Is There a New CAR T-Cell Treatment for Mantle Cell Lymphoma?
Mantle cell lymphoma is a type of B-cell non-Hodgkin lymphoma with a typically poor prognosis. Even with an allogeneic stem cell transplant, patients can become resistant to chemotherapy. Most do not survive 4 or 5 years after diagnosis, and the 10-year survival rate hovers between 5% and 10%.
Genetic Testing May Benefit Older Women With Breast Cancer
The 2 main criteria that warrant genetic testing for breast cancer in women are age and having a family history of cancer. Postmenopausal women without any hereditary risk factors, however, often do not undergo genetic testing for the disease.
Evolocumab Lowers LDL-C in HIV-Positive Persons
Evolocumab (Repatha), a human monoclonal antibody and proprotein convertase subtilisin/kexin type 9 inhibitor, produced positive results in persons living with HIV in the BEIJERINCK study by reducing their levels of low-density lipoprotein cholesterol (LDL-C). These individuals have a risk of cardiovascular disease that is almost twice that of HIV-negative individuals.
Possible Link Found Between Early Heart Failure and Pregnancy Complications
Pregnancy complications that include preeclampsia, gestational hypertension, pre-term birth, and low birthweight serve as possible indicators for greater risk of heart failure in the long term, as indicated by change in global longitudinal strain on echocardiogram.
AB MRI Shown to Improve Cancer Detection Rate in Women With Dense Breast Tissue
Not all women with dense breast tissue have a high risk of breast cancer, but they all have an increased risk compared with women who have average tissue density. Can this patient population benefit from screening with abbreviated breast magnetic resonance imaging (AB MRI) over digital breast tomosynthesis?
Mortality, Risk Factors of Patients With Cardiac Injury and COVID-19
Evidence is considered lacking on the association between mortality and patients who have both cardiac injury and coronavirus disease 2019 (COVID-19). Is the rate of death higher among these patients compared with patients without cardiac disease who have COVID-19?
COVID-19 Questions HIV-Positive Individuals Want Answered
The environment surrounding the coronavirus disease 2019 (COVID-19) pandemic seems to change by the minute. The full extent to which HIV-positive individuals can be affected if they contract COVID-19, because they are immunocompromised, is not known. Recently, the CDC issued guidance for this patient population.
Clinical Variable Model More Reliable at Predicting Mortality Among Veterans
Are coding changes responsible for declines in the 30-day mortality rate for hospital admissions among veterans utilizing Veterans Health Administration medical centers? Which model is more accurate at predicting this measure: a claims-based model or a clinical factor–based model?
Study Results Recommend Ongoing, but Updated, HIV-1/HIV-2 Differentiation Testing
Between 2010 and 2017, there were 327,700 new HIV infections in the United States. Of these, HIV-2 infections accounted for less than 0.03% of the total. It is important to differentiate which HIV strain an individual is infected with because HIV-2 is intrinsically resistant to nonnucleoside reverse-transcriptase inhibitors, which are typically used to treat HIV-1 infections.
Palliative Care Is Underutilized for Patients With Heart Failure
By 2030, heart failure—which tops the list of reasons for hospitalization among individuals older than 65 years—could tax the healthcare system $69.8 billion each year. Study results show the success of palliative care at reducing both healthcare costs and hospitalization.
CVD Risk Faces Undue Influence From Social Determinants of Health
Social determinants found within a person’s environment, mainly where they live and work, have been shown to influence outcomes related to health, functioning, and quality of life, especially where risk of cardiovascular disease (CVD) is concerned, according to study results that will be presented during ACC.20/WCC Virtual.
Novel Blood Biopsy Detects MRD in Early-Stage Breast Cancer
Metastatic disease is the leading cause of death in the over 600,000 individuals worldwide who die of breast cancer each year. A new blood-based assay to detect minimal residual disease (MRD) in patients with stage 0 to 3 breast cancer was shown to have 100-fold greater sensitivity compared with digital droplet polymerase chain reaction.
Does Germline Variant Status Influence Treatment Outcome?
A primary analysis of data from the GeparOcto trial showed no difference in pathologic complete response among patients with early-stage breast cancer enrolled in 2 neoadjuvant treatment arms: sequential intense dose-dense epirubicin, paclitaxel, and cyclophosphamide and weekly paclitaxel and nonpegylated liposomal doxorubicin.
Does Treatment Begin and End Sooner With Neoadjuvant or Adjuvant Chemotherapy?
Patients who undergo neoadjuvant chemotherapy tend to be younger, with larger tumors and greater nodal involvement. But differences in their 30- and 90-day mortality rates compared with those of patients treated adjuvantly are clinically insignificant.